v3 Template
P

Parabilis Medicines

Biotechnology/Pharmaceuticals Cambridge, Massachusetts, USA ~700 employees
Founded
--
Employees (Est.)
~700
35 leaders known
Total Funding
$1.8B
Funding Rounds
3
Last Funding
2026-06-11

About Parabilis Medicines

Parabilis Medicines, formerly FogPharma, is dedicated to creating extraordinary medicines with a focus on ultra-tunable peptide therapeutics. Their mission is to achieve life-changing outcomes for patients with severe diseases, particularly in areas like cancer, by leveraging a custom-built research engine and innovative platforms.

Products & Services

Helicon™ Peptide Platform:An ultra-tunable peptide therapeutics platform designed to develop novel medicines for cancer and other critical diseases.
Programs:Innovative treatment programs aimed at fundamentally changing possibilities for severe diseases.
Helicon™ peptide therapeutics

Specialties

Ultra-tunable peptide therapeutics Cancer treatment AI and physics-based discovery platform ultra-tunable peptide therapeutics antibody-helicon conjugates

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: IPO
T: -
FT: IPO
A: 845500000
MR: -
FA: $845.5 million
FAN: 845500000
D: 2026-06-11
FD: 2026-06-11
2 investors
2 RT: IPO
T: -
FT: IPO
A: 670000000
MR: -
FA: 670000000
FAN: 670000000
D: 2026-06-09
FD: 2026-06-09
6 investors
3 RT: Series F
T: -
FT: Series F
A: 305000000
MR: -
FA: $305 million
FAN: 305000000
D: 2026-01-08
FD: 2026-01-08
23 investors
IPO Latest
2026-06-11
$845.5M
2 investors (Pro only)
IPO 2026-06-09
$670.0M
Series F 2026-01-08
$305.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Mathai Mammen

Chairman, CEO and President

F

Fawzi Benzaghou

Chief Medical Officer

M

Markus Haeberlein

Executive Vice President, Discovery Science

H

Helen Ho

Chief Business and Strategy Officer

J

Jonathan Hurov

Executive Vice President, Discovery Biology

T

Teresa Jurgensen

Executive Vice President, General Counsel

View 32 more team members with Pro

Unlock Full Team Directory

Recent News

Parabilis Medicines Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Pharmaceuticals
Company Size
~700 employees (est.)
Locations
Cambridge, Massachusetts, USA
Cambridge, MA, USA
Cambridge, Massachusetts

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro